Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 8—August 2012
Dispatch

Severe Human Granulocytic Anaplasmosis Transmitted by Blood Transfusion

Matjaz JerebComments to Author , Blaz Pecaver, Janez Tomazic, Igor Muzlovic, Tatjana Avsic-Zupanc, Tanja Premru-Srsen, Snezna Levicnik-Stezinar, Primoz Karner, and Franc Strle
Author affiliations: University Medical Center Ljubljana, Ljubljana, Slovenia (M. Jereb, B. Pecaver, J. Tomazic, I. Muzlovic, T. Premru-Srsen); Institute of Microbiology and Immunology, Ljubljana (T. Avsic-Zupanc); and Blood Transfusion Center of Slovenia, Ljubljana (S. Levicnik-Stezinar)

Main Article

Table 1

Blood test results for a patient with severe human granulocytic anaplasmosis, Slovenia, 2010*

Date, 2010 CRP, mg/L PCT, µg/L Leukocytes, 109 cells/L Band cells, % Erc, 1012 cells/L Hb, g/L Pt, 109/L LDH, μkat/L AF, μkat/L AST, μkat/L ALT, μkat/L GGT, μkat/L
Sep

13

 <3 ND 8.2 ND 4.23 113 230 2.67 1.8 0.46 0.53 0.19

16

 45 ND 11.1 ND 4.57 127 142 3.74 1.5 0.78 0.53 0.23

25

 97 ND 9.2 ND 4.76 128 258 ND 2.54 1.39 1.65 ND

27

 95 0.75 6.2 ND 3.91 106 80 6.1 3.56 1.39 1.12 2.67

28

 120 0.73 9.1 48 3.67 104 39 8.28 5.3 1.9 1.17 3.07

29

 167 0.98 10 23 3.82 106 21 9.23 6.11 2.74 1.33 2.98

30

 121 1.02 9.4 15 3.79 106 11 13.6 5.75 3.69 1.36 2.95
Oct

1

 88 0.83 6 10 3.92 111 21 18.12 5.07 4.06 1.29 3.28

2

 60 1 12 10 3.94 104 50 23.2 4.3 4.86 1.48 3.8

5

 34 0.23 13.9 3 3.2 91 52 16.03 3.33 1.8 1.4 4.06

6

 15 0.19 14.3 2 3.38 97 141 10.48 2.72 1.2 1.52 3.21

7

 4 ND 12 2 3.52 101 210 7.41 2.49 0.97 1.99 3.11

8

 ND ND 11.5 0 3.54 104 275 6.03 2.23 0.73 1.83 2.77

10

 <3 ND 8.5 0 3.96 107 401 5.65 2.11 0.62 1.5 2.62

*CRP, C-reactive protein (reference <5 mg/L); PCT, procalcitonin (reference <0.5 µg/L); leukocytes, leukocyte count (reference 4–10 × 109 cells/L); Erc, erythrocyte count (reference 4.2–5.4 x 1012 cells/L); Hb, hemoglobin (reference120–160 g/L); Pt, platelets (reference 140–340 × 109/L); LDH, lactate dehydrogenase (reference <4.12 μkat/L); AF, alkaline phosphatase (referrence <1.74 μkat/L); AST, aspartate transaminase (reference <0.52 μkat/L); ALT, alanine transaminase (reference <0.56 μkat/L); GGT, γ-glutamyl transferase (reference <0.63 μkat/L); ND, not determined.

Main Article

Page created: July 19, 2012
Page updated: July 19, 2012
Page reviewed: July 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external